Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
AIDS Research and Human Retroviruses
|
January 1, 1996
Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease
H Mo, M Markowitz, P Majer, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 1999
Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2' ligand
R S Randad, L Lubkowska, M A Eissenstat, et al.
Biochemistry
|
December 23, 1998
Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
E M Towler, S V Gulnik, T N Bhat, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors
S F Martin, G O Dorsey, T Gane, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 17, 1996
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum
A M Silva, A Y Lee, S V Gulnik, et al.
Journal of Medicinal Chemistry
|
November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease
B D Tait, S Hagen, J Domagala, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease
F E Boyer, J V Vara Prasad, J M Domagala, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
AIDS Research and Human Retroviruses
|
January 1, 1996
Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease
H Mo, M Markowitz, P Majer, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 1999
Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2' ligand
R S Randad, L Lubkowska, M A Eissenstat, et al.
Biochemistry
|
December 23, 1998
Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
E M Towler, S V Gulnik, T N Bhat, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors
S F Martin, G O Dorsey, T Gane, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 17, 1996
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum
A M Silva, A Y Lee, S V Gulnik, et al.
Journal of Medicinal Chemistry
|
November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease
B D Tait, S Hagen, J Domagala, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease
F E Boyer, J V Vara Prasad, J M Domagala, et al.
Page
of 2